Stuart McLaren

Author PubWeight™ 208.06‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Initial sequencing and comparative analysis of the mouse genome. Nature 2002 96.15
2 Massive genomic rearrangement acquired in a single catastrophic event during cancer development. Cell 2011 16.72
3 Exome sequencing identifies frequent mutation of the SWI/SNF complex gene PBRM1 in renal carcinoma. Nature 2011 13.30
4 The patterns and dynamics of genomic instability in metastatic pancreatic cancer. Nature 2010 12.43
5 The landscape of cancer genes and mutational processes in breast cancer. Nature 2012 11.24
6 Mutational processes molding the genomes of 21 breast cancers. Cell 2012 11.22
7 The life history of 21 breast cancers. Cell 2012 10.59
8 The zebrafish reference genome sequence and its relationship to the human genome. Nature 2013 8.52
9 The DNA sequence of the human X chromosome. Nature 2005 6.97
10 Clinical and biological implications of driver mutations in myelodysplastic syndromes. Blood 2013 6.50
11 Analyses of pig genomes provide insight into porcine demography and evolution. Nature 2012 5.58
12 hORFeome v3.1: a resource of human open reading frames representing over 10,000 human genes. Genomics 2007 4.62
13 Disease-associated XMRV sequences are consistent with laboratory contamination. Retrovirology 2010 2.90
14 Single-cell paired-end genome sequencing reveals structural variation per cell cycle. Nucleic Acids Res 2013 1.77
15 Whole exome sequencing of adenoid cystic carcinoma. J Clin Invest 2013 1.58
16 The genetic heterogeneity and mutational burden of engineered melanomas in zebrafish models. Genome Biol 2013 1.54
17 Frequent mutation of the major cartilage collagen gene COL2A1 in chondrosarcoma. Nat Genet 2013 1.45
18 Genomic anatomy of the Tyrp1 (brown) deletion complex. Proc Natl Acad Sci U S A 2006 1.07
19 Corrigendum: analysis of the genetic phylogeny of multifocal prostate cancer identifies multiple independent clonal expansions in neoplastic and morphologically normal prostate tissue. Nat Genet 2015 0.79
20 Polygenic in vivo validation of cancer mutations using transposons. Genome Biol 2014 0.75